SULFADIAZINE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Sulfadiazine Sodium patents expire, and when can generic versions of Sulfadiazine Sodium launch?
Sulfadiazine Sodium is a drug marketed by Lederle and is included in one NDA.
The generic ingredient in SULFADIAZINE SODIUM is sulfadiazine sodium. There are nineteen drug master file entries for this compound. Additional details are available on the sulfadiazine sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFADIAZINE SODIUM?
- What are the global sales for SULFADIAZINE SODIUM?
- What is Average Wholesale Price for SULFADIAZINE SODIUM?
Summary for SULFADIAZINE SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Patent Applications: | 183 |
| DailyMed Link: | SULFADIAZINE SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SULFADIAZINE SODIUM
US Patents and Regulatory Information for SULFADIAZINE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | SULFADIAZINE SODIUM | sulfadiazine sodium | INJECTABLE;INJECTION | 004054-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
